Sep 2, 2026LATEST SOURCED
other
Thyme Care expands its oncology platform
Investors undisclosed
Amount$125MValuationUndisclosed
← Company explorer
Captables
TH
COMPANY PROFILE
Thyme Care
Tracked in the Captables newsroom
Historical ranking valuationUndisclosedNo reviewed valuation record
Disclosed primary funding in this record
Not establishedSum of non-overlapping disclosed USD amounts in confirmed primary financing entries in this record, including separately labeled equity components; not verified lifetime funding. Excludes amounts already included in a later round, announced, reported, database-only, debt, secondary and unclassified events.
0 confirmed primary rounds with disclosed USD amounts · Record through 2026-11-01THE BUSINESS
Get to know Thyme Care.
A reviewed business overview has not been published for this company. Its public financing record is available below.
Contribute a company source →Valuation history
Valuations reported at the time of each round.
No dated financing valuation has passed into this record.
Funding history
Funding rounds, debt and other financing events.
1sourced event · record as of 2026-11-01
Headline association; not a reviewed issuer link. Unlinked article observations are not independently reconciled financing events. This is covered public-source history, not an exhaustive issuer ledger.
Financing participants
Investors, lenders and other parties named in funding announcements.
No named participant has been added to this company’s public financing record.
Ownership evidence
Opening ownership research…
Captables coverage
Deals / Captables
Thyme Care raises $125M and expands from navigation into oncology infrastructure
Thyme Care coordinates cancer patients, providers, and health plans through a technology-enabled care model; its Series E also funds a new parent company for additional oncology businesses.
Captables Newsroom · 58d ago